NET ASSET VALUE – 31 October 2024

MARKN.

On the 31 October 2024 Flerie AB's Net Asset Value (NAV) was SEK 4,377 million and NAV per share was SEK 56.06.

Allocation of NAVShare of portfolio companyFair value (MSEK)Part of NAV per share (SEK)Share of NAV
Product Development    
Prokarium42%4886.2511.1%
Xspray Pharma18%3514.508.0%
Empros Pharma79%2042.624.7%
KAHR Medical31%2022.594.6%
Atrogi37%1762.254.0%
Lipum57%1732.224.0%
Xintela56%1431.843.3%
Microbiotica11%1391.783.2%
Mendus24%1231.572.8%
Geneos Therapeutics12%1031.312.3%
Toleranzia66%901.152.1%
EpiEndo Pharmaceuticals9%580.741.3%
Synerkine Pharma43%530.681.2%
AnaCardio19%520.661.2%
Egetis Therapeutics2%310.400.7%
Buzzard Pharmaceuticals14%290.370.7%
Vitara Biomedical8%290.370.7%
Sixera Pharma23%260.330.6%
Alder Therapeutics21%170.220.4%
Amarna Therapeutics58%120.150.3%
Strike Pharma16%90.110.2%
Total 2,50732.1157.3%





Commercial Growth   
NorthX Biologics92%1892.424.3%
Symcel31%1692.163.9%
Provell Pharmaceuticals72%750.961.7%
Chromafora31%730.931.7%
Nanologica38%710.911.6%
A3P Biomedical8%420.541.0%
Frontier Biosolutions2%190.250.4%
Bohus Biotech45%170.210.4%
Total 6548.3814.9%





Limited Partnerships, total 941.212.2%
     
Assets related to Portfolio companies 3164.057.2%
Other assets and liabilities 80510.3118.4%
     
Net asset value 4,37756.06100.0%
  

 

    

* indirect shares in Provell Pharmaceuticals

Datum 2024-11-04, kl 08:00
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!